FDA Approves Pediatric Formulation of Proton-Pump InhibitorFDA Approves Pediatric Formulation of Proton-Pump Inhibitor

"Sprinkle" formulation of rabeprazole sodium is now licensed for treating GERD in children aged 1-11 years. FDA Approvals
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news